Education
About Us
Working with TipRanks
Follow Us
MedCap AB (SE:MCAP)
:MCAP
See the Price Targets and Ratings of:
MCAP Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
kr548
Buy
4.78%
Upside
Upgraded
07/08/25
MedCap AB's robust financial performance is the key strength, contributing most significantly to the overall score. The strong upward trend in technical analysis is dampened by overbought signals. The high P/E ratio indicates a premium valuation, and the absence of earnings call and corporate events data means these factors do not impact the score.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
kr548
Buy
4.78%
Upside
Upgraded
07/08/25
MedCap AB's robust financial performance is the key strength, contributing most significantly to the overall score. The strong upward trend in technical analysis is dampened by overbought signals. The high P/E ratio indicates a premium valuation, and the absence of earnings call and corporate events data means these factors do not impact the score.
Best Analysts Covering MedCap AB
1 Month
xxx
Success Rate
2/2 ratings generated profit
Average Return
+3.40%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +3.40% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
Average Return
+7.85%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +7.85% per trade.
1 Year
Success Rate
2/2 ratings generated profit
Average Return
+16.90%
reiterated a buy rating last month
Copying Valerie Balancia's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +16.90% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
Average Return
+7.85%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +7.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MCAP Analyst Recommendation Trends
Rating
May 25
Jun 25
Strong Buy
1
3
Buy
0
0
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
1
3
Each month's total comprises the sum of three months' worth of ratings.
MCAP Stock Forecast FAQ
What is SE:MCAP’s average 12-month price target, according to analysts?
Based on analyst ratings, MedCap AB’s 12-month average price target is 479.04.
What is SE:MCAP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:MCAP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MedCap AB a Buy, Sell or Hold?
MedCap AB has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is MedCap AB’s share price target?
The average share price target for MedCap AB is 479.04. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr479.04 ,and the lowest forecast is kr479.04. The average share price target represents -8.41% Decrease from the current price of kr523.
The highest analyst share price target is kr479.04 ,and the lowest forecast is kr479.04. The average share price target represents -8.41% Decrease from the current price of kr523.
What do analysts say about MedCap AB?
MedCap AB’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of MedCap AB?
To buy shares of SE:MCAP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.